ORIGINAL ARTICLE   

Minerva Dental and Oral Science 2023 February;72(1):8-15

DOI: 10.23736/S2724-6329.21.04572-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

The IRF6 AP-2α binding site polymorphism relate to the severity of non-syndromic orofacial cleft of Indonesian patients

Saskia L. NASROEN ¹ ✉, Ani M. MASKOEN ², Hardisiswo SOEDJANA ³, Dany HILMANTO ⁴, Basri A. GANI ⁵

¹ Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universitas Jenderal Achmad Yani Cimahi, Bandung, Indonesia; ² Department of Oral Biology, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia; ³ Division of Plastic Surgery Reconstruction and Esthetic, Department of Surgery, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; ⁴ Department of Pediatrics, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; ⁵ Department of Oral Biology, Faculty of Dentistry, Universitas Syiah Kuala, Aceh, Indonesia

BACKGROUND: IRF6 AP-2α binding site polymorphism is known as IRF6 rs642961. It has been associated with a nonsyndromic orofacial cleft (NS OFC). This study aimed to determine the IRF6 rs642961 as a risk factor associated with NS OFC and its phenotypes.
METHODS: The case-control design used for 264 subjects consists of 158 NS CLP subjects (42 CU CLP, 34 CB CLP, 33 CLO, 49 CPOs) and 106 healthy controls. The DNA is extracted from venous blood. The segment of IRF6 rs642961 amplified by polymerase chain reaction (PCR) followed by restriction fragment length of polymorphisms (RFLPs) used the MspI digestion enzyme. The qPCR method to identify the mRNA expression levels of the IRF6 gene rs642961 was analyzed by the Livak method.
RESULTS: The study results show that in NS CB CLP phenotype as the most severe phenotype of NS OFC, the Odds Ratio (OR) of A mutant allele was 5.094 (CI=1.456-17.820; P=0.011) and the OR of AA homozygous mutant genotype was 13.481 (CI=2.648-68.635; P=0.001). There are different levels of mRNA expression changes from NS OFC and its phenotypes. It is substantial among the 2^-ΔΔCt and the group of AA, GA, and GG genotypes (P<0.05); in the NS CPO phenotype, it shows IRF6 mRNA under-expression in GA, AA genotypes while in other phenotypes it shows IRF6 mRNA overexpression.
CONCLUSIONS: The IRF6 AP-2α binding site polymorphism is strongly associated with the severity of NS OFC, and this polymorphism has a functional role in affecting IRF6 mRNA expression that is variable in each phenotype.

KEY WORDS: Orofacial cleft 1; Genes; Dental health services